Literature DB >> 27698125

Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses.

Wanwan Huai1, Hui Song1, Zhongxia Yu1, Wenwen Wang1, Lihui Han1, Takeharu Sakamoto2, Motoharu Seiki3, Lining Zhang1, Qunye Zhang4, Wei Zhao5.   

Abstract

Type I IFNs (IFN-α/β) play crucial roles in the elimination of invading viruses. Multiple immune cells including macrophages recognize viral infection through a variety of pattern recognition receptors, such as Toll-like receptors (TLRs) and retinoic acid-inducible gene-I (RIG-I)-like receptors, and initiate type I IFN secretion and subsequent antiviral immune responses. However, the mechanisms by which host immune cells can produce adequate amounts of type I IFNs and then eliminate viruses effectively remain to be further elucidated. In the present study, we show that munc18-1-interacting protein 3 (Mint3) expression can be markedly induced during viral infection in macrophages. Mint3 enhances TLR3/4- and RIG-I-induced IRF3 activation and IFN-β production by promoting K63-linked polyubiquitination of TNF receptor-associated factor 3 (TRAF3). Consistently, Mint3 deficiency greatly attenuated antiviral immune responses and increased viral replication. Therefore, we have identified Mint3 as a physiological positive regulator of TLR3/4 and RIG-I-induced IFN-β production and have outlined a feedback mechanism for the control of antiviral immune responses.

Entities:  

Keywords:  RIG-I; TLR; TRAF3; interferon; viral infection

Mesh:

Substances:

Year:  2016        PMID: 27698125      PMCID: PMC5081575          DOI: 10.1073/pnas.1601556113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  X11L2, a new member of the X11 protein family, interacts with Alzheimer's beta-amyloid precursor protein.

Authors:  H Tanahashi; T Tabira
Journal:  Biochem Biophys Res Commun       Date:  1999-02-24       Impact factor: 3.575

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 4.  Dynamic control of type I IFN signalling by an integrated network of negative regulators.

Authors:  Rebecca A Porritt; Paul J Hertzog
Journal:  Trends Immunol       Date:  2015-02-25       Impact factor: 16.687

5.  Phosphatase PTPN4 preferentially inhibits TRIF-dependent TLR4 pathway by dephosphorylating TRAM.

Authors:  Wanwan Huai; Hui Song; Lijuan Wang; Bingqing Li; Jing Zhao; Lihui Han; Chengjiang Gao; Guosheng Jiang; Lining Zhang; Wei Zhao
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

Review 6.  New developments in the induction and antiviral effectors of type I interferon.

Authors:  Su-Yang Liu; David Jesse Sanchez; Genhong Cheng
Journal:  Curr Opin Immunol       Date:  2010-11-29       Impact factor: 7.486

Review 7.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

8.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.

Authors:  Ping-Hui Tseng; Atsushi Matsuzawa; Weizhou Zhang; Takashi Mino; Dario A A Vignali; Michael Karin
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

Review 9.  The yin and yang of viruses and interferons.

Authors:  Ben X Wang; Eleanor N Fish
Journal:  Trends Immunol       Date:  2012-02-07       Impact factor: 16.687

10.  Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity.

Authors:  Wendy J van Zuylen; Priscilla Doyon; Jean-François Clément; Kashif Aziz Khan; Lisa M D'Ambrosio; Florence Dô; Myriam St-Amant-Verret; Tasheen Wissanji; Gregory Emery; Anne-Claude Gingras; Sylvain Meloche; Marc J Servant
Journal:  PLoS Pathog       Date:  2012-07-05       Impact factor: 6.823

View more
  12 in total

1.  HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.

Authors:  Fubing Li; Yang Li; Huichun Liang; Tao Xu; Yanjie Kong; Maobo Huang; Ji Xiao; Xi Chen; Houjun Xia; Yingying Wu; Zhongmei Zhou; Xiaomin Guo; Chunmiao Hu; Chuanyu Yang; Xu Cheng; Ceshi Chen; Xiaopeng Qi
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

2.  MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis.

Authors:  S Li; X Liang; L Ma; L Shen; T Li; L Zheng; A Sun; W Shang; C Chen; W Zhao; J Jia
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

3.  UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression.

Authors:  Hui Song; Chunyuan Zhao; Zhongxia Yu; Qizhao Li; Rongzhen Yan; Ying Qin; Mutian Jia; Wei Zhao
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

4.  Redox homeostasis maintained by GPX4 facilitates STING activation.

Authors:  Mutian Jia; Danhui Qin; Chunyuan Zhao; Li Chai; Zhongxia Yu; Wenwen Wang; Li Tong; Lin Lv; Yuanyuan Wang; Jan Rehwinkel; Jinming Yu; Wei Zhao
Journal:  Nat Immunol       Date:  2020-06-15       Impact factor: 25.606

5.  USP1-UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses.

Authors:  Zhongxia Yu; Hui Song; Mutian Jia; Jintao Zhang; Wenwen Wang; Qi Li; Lining Zhang; Wei Zhao
Journal:  J Exp Med       Date:  2017-11-14       Impact factor: 14.307

Review 6.  Viruses Seen by Our Cells: The Role of Viral RNA Sensors.

Authors:  Elias A Said; Nicolas Tremblay; Mohammed S Al-Balushi; Ali A Al-Jabri; Daniel Lamarre
Journal:  J Immunol Res       Date:  2018-04-30       Impact factor: 4.818

Review 7.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

8.  KAT8 selectively inhibits antiviral immunity by acetylating IRF3.

Authors:  Wanwan Huai; Xingguang Liu; Chunmei Wang; Yunkai Zhang; Xi Chen; Xiang Chen; Sheng Xu; Tim Thomas; Nan Li; Xuetao Cao
Journal:  J Exp Med       Date:  2019-03-06       Impact factor: 14.307

9.  Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury.

Authors:  Shaojun Ye; Qifa Ye; Wei Zhou; Zibiao Zhong; Danni Lin; Zhongzhong Liu; Qiuyan Zhang; Haoyang Xia; Sheng Peng; Anxiong Liu; Zhongshan Lu; Yanfeng Wang
Journal:  Cell Death Dis       Date:  2021-02-24       Impact factor: 8.469

Review 10.  Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Biomedicines       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.